613.jpg)
Serum Institute of India (SII) has produced 10.8 crore doses of its COVID-19 vaccine Covishield in June so far, according to information provided to the Drugs Controller General of India (DCGI). The company sent 45 batches of Covishield to the Central Drugs Laboratory, Kasauli for release during the month. Recently, SII began production of Novavax's COVID-19 vaccine Covovax in India.
Serum Institute of India (SII) has produced 10.8 crore doses of its COVID-19 vaccine Covishield in June so far, according to information provided to the Drugs Controller General of India (DCGI). The company sent 45 batches of Covishield to the Central Drugs Laboratory, Kasauli for release during the month. Recently, SII began production of Novavax's COVID-19 vaccine Covovax in India.
417.jpeg)
10.jpeg)
40.jpeg)
100.jpeg)
416.jpeg)
5.jpeg)
4.jpeg)
6.jpeg)
5.jpeg)
